http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2565035-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a708524c0adee3eb5b130dac053f9c3d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-25125 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6806 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6821 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6848 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-9493 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2007-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65428028a04325d6adc1a878c56c0999 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3edafbbd5f98896b4b946f485eec8770 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f908b2187f4ad1686c0c03e954de5c72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b15e776b81e201c9467f209f342a9bfa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f69d245350af24bbcc7c43a4f8940e2 |
| publicationDate | 2016-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2565035-T3 |
| titleOfInvention | Methods to evaluate peptide mixtures |
| abstract | A method for testing a sample of glatiramer acetate, the method comprising: (a) providing the sample of glatiramer acetate, where it is suspected that the sample comprises one or more polypeptides having a diethylamide moiety attached to a C-terminus of the themselves; (b) determine the amount of polypeptides having a diethylamide moiety attached to a C-terminus thereof in the sample by detecting diethylamide moieties when they are present at the C-terminus; (c) compare the amount of polypeptides having the diethylamide moiety attached to a C-terminus thereof in the sample with a predetermined pharmaceutical specification value for glatiramer acetate, where the specification value for glatiramer acetate has a range of about 7 mol% to about 20 mol% of polypeptides having a diethylamide moiety attached to a C-terminus thereof; and (d) classifying the sample based on the amount of polypeptides having diethylamide moieties attached to the C-terminus thereof in the sample, wherein the classification of the sample comprises approving the sample for pharmaceutical use. |
| priorityDate | 2006-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 125.